New breast cancer drug now availablemagic band logo in China

Take Flights To Italy To Attend The Grand Pistoia Blues Festival 2010 In Italy! The bottom line is this: No one has made a wristband that the "bad guys" cannot beat. But by using wristbands, we just make their lives a little more difficult. In Cleveland, avant-garage legends Pere Ubu performed their influential 1978 post-punk watershed album "The Modern Dance" in its entirety for a live audience at the Beachland Ballroom this year - helping the North Collinwood club celebrate its 10-year anniversary. Ideally, when I say "on the street," I mean somewhere that"s bustling with activity, like a festival wristbands or an arts crafts booth fair - these are great places to try these techniques to learn how to pick up women. Start a conversation with a girl about someone or something that"s around you both. Maybe someone"s wearing a really weird outfit. Or maybe there"s a cute dog that"s wearing a tutu. Share that with a girl and then you"re in a conversation with her. Next up nature event wristbands decided it too was a Lefty because here comes that bitch Katrina. The wind and rain did little damage and the bullet was dodged. Oil platforms were not wrecked beyond repair. The port facilities were not rendered destroyed, but that bitch Katrina had an ace up her sleeve. What you do before and after the date destination sport wristbands can make or break the date so mentally walk through the date ahead of time to be sure you have covered how you will get there who will drive home or will you cab it? Being spontaneous is really fun too - so if you know your partner well enough you could even pack a surprise bag for them and stay overnight somewhere after the date. The next band I spoke with was Company. Company is a self-described indie rock sounding band. The band members are now living in Charleston, South Carolina. Used to playing empty bar rooms, Company is excited to be playing at the SXSW festival this year. For more ideas about themes and Swap Parties, there are many fun resources to check. One such resource is Recycling Week, which provides a very detailed look at what to consider and how to host one.
[Photo/VCG]

Advanced breast cancer patients in China now have another treatment option other than chemotherapy to choose from following the approval of a new oral drug called Ibarnce by the China Food and Drug Administration.

Developed by US-based pharmaceutical company Pfizer, Ibarnce is presently available to patients in 35 Chinese cities.

According to Dennis Slamon, one of the lead scientists in the development of Ibarnce who visited Shanghai in October, the consumption of the pill does not have severe side effects like chemotherapy such as hair loss, nausea and vomiting.

Breast cancer is ranked as the most common form of cancer in women in China. According to the 2017 China Cancer Registration Annual Report released by the National Cancer Center, there are about 280,000 new cases each year.

The report also showed that about one-tenth of patients already suffer from advanced breast cancer when diagnosed, while about one-third of those who detect the condition early and have undergone surgery or standardized treatment will still develop advanced breast cancer. The five-year survival rate of advanced breast cancer is only about 20 percent.

Slamon said he hopes the drug, which can effectively stop cancer cells from proliferating, can bring more hope to Chinese patients as it has done in the US, where it was approved in 2015. The scientist also hopes that the availability of this new drug in China might inspire Chinese physicians to come up with different treatment combinations.

“Ibarnce is probably the first drug of targeted therapy that is able to postpone drug resistance happening to patients after they receive endocrine therapies,” said Xu Binghe, head of internal medicine at the Cancer Hospital of the Chinese Academy of Medical Sciences in Beijing.

The drug is also being tested in early breast cancer, according to Slamon, who added that China is included in its worldwide clinical trials.

Pfizer is also collaborating with major university centers in Dalian, Liaoning province, Beijing and Shanghai in the research and development of treatments for early breast cancer patients, said Slamon.